Prof Dr Nada Hamad

President

Prof Nada Hamad is a senior staff specialist bone marrow transplant, cellular therapies, clinical and laboratory haematologist at St Vincent’s hospital in Sydney, where she is also director of the haematology clinical trials unit. She is Chair of the ACI NSW BMT network and Chair of ALLG BMTCT working group. She also has a number of international leadership positions including membership of the WHO BMT quality taskforce. Dr Hamad studied Medicine at the University of Sydney and completed her Haematology training in Sydney. Prior to her career in medicine, she completed a Bachelor of Science and Master of Science in Forensics, working in this field for a short period of time. She completed two post-graduate fellowships in BMT and lymphoma at the Princess Margaret Cancer Centre in Toronto Canada through the University of Toronto. She has a strong interest in clinical trials and has a specialist certificate in Clinical Research (Oncology) from the University of Melbourne. Her clinical research interests are in malignant haematology and bone marrow transplantation. She is an intersectional feminist and a strong advocate for gender equity, diversity and inclusion in medicine. She is the deputy chair of the gender equity, diversity and inclusion in medicine committee at the University of NSW in Australia.

Dr Duncan Purtill

Vice President

Dr Duncan Purtill is a laboratory and clinical haematologist and medical director of the Bone Marrow Transplant Laboratory at Fiona Stanley Hospital in Perth. He obtained his undergraduate degree from the University of Western Australia and completed most of his postgraduate training at Royal Perth Hospital. He has completed research and clinical fellowships in bone marrow transplantation, with a particular interest in cord blood transplantation, at Hôpital Saint Louis in Paris and at Memorial Sloan Kettering Cancer Centre in New York.

Dr Jason Butler

Treasurer

Dr Jason Butler is a senior staff specialist at the Bone Marrow transplant Unit, Royal Brisbane and Women’s Hospital, and Visiting Medical Officer with Icon Cancer Centre. He has dual training in clinical and laboratory haematology. Dr Butler also completed a Masters in Medical Science (Clinical Epidemiology) to assist with development of investigator-initiator research studies. His major clinical interests are in lymphoma, and myeloma, as well as autologous and allogeneic stem cell transplantation, and cellular therapies. Dr Butler also undertakes other roles, including extensive educational support and clinical presentations for patients and health professionals, as a longstanding member of Haematology and BMT eviQ reference committees, and advocacy roles as a board member for Lymphoma Australia.

A/Prof Ashish Bajel

Secretary

A/Prof Ashish Bajel is a clinical and BMT Haematologist, at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre. He is the disease group co -lead for acute leukaemia and myelodysplastic syndrome. He oversees the umbilical cord blood and haplo-identical stem cell  transplant programs at the Royal Melbourne Hospital. He is a member of disease group committees in the Australasian Leukaemia and Lymphoma Group (ALLG) and CIBMTR. He is actively involved in  clinical and translational research aimed at developing new treatments for acute leukaemia and improving outcomes in allogeneic transplant.

Dr Richard Doocey

Director

Dr Richard Doocey

Dr Richard Doocey is a clinical and BMT haematologist and Director of the Auckland and Starship Children’s Hospital’s Stem Cell Transplant Program He was also Clinical Director of the Adult Haematology Service for 7 years until 2017. He completed training in Auckland, New Zealand and and subspecialty training in acute leukaemia, high grade lymphoma and bone marrow transplantation at Vancouver General Hospital and the British Columbia Cancer Agency. Richard also holds an appointment as the chair of the NZ Haematology Work Group interacting with the Ministry of Health.

A/Prof Theresa Cole

Board Appointed Director

A/Prof Theresa Cole is a Paediatric Allergist Immunologist andCo-Clinical Lead for the Haematopoietic Stem Cell Transplant Service at Royal Children’s Hospital in Melbourne. After completing training in paediatric immunology & infectious disease and obtaining her PhD in the UK, Theresa moved to Melbourne in 2014 to take on a role at The Royal Children’s Hospital with a focus on stem cell transplant for primary immunodeficiency (PID) She has been Chair of the ASCIA TAPID project since 2014, Chair of the ASCIA Immunodeficiency Committee from 2018 until 2022 and current ASCIA President. Theresa is involved in a number of clinical trials in HSCT and author of national guidelines for management of children with Severe Combined Immunodeficiency.

Prof David Yeung

Board Appointed Director

Professor David Yeung is a clinical and laboratory haematologist with a special interest in acute and chronic leukaemia. He grew up and trained in Sydney, qualifying as a haematologist in 2010, and obtaining his PhD in Chronic Myeloid Leukaemia (CML) in 2015. David currently holds appointments with the Royal Adelaide Hospital as a consultant haematologist, at the SAHMRI as a clinical research fellow, and holds the title of clinical senior lecturer with the University of Adelaide Medical School. He heads a number of clinical trials in CML and Acute Lymphoblastic Leukaemia (ALL). He has published a number of papers on his work, and is a contributing author in CML text books, and contributes to a number of reference committees and advisory boards on his areas of research interest. His particular expertise is in CML, ALL and stem cell transplantation.

Ms Megan Hogg

Board Appointed Director

Ms Megan Hogg is a Clinical Nurse Specialist in Long Term Follow-up BMT at Westmead Hospital, Sydney. 

Dr Annette Trickett

Board Appointed Director

Dr Annette Trickett is the Principal Scientist / Director of the Blood and Marrow Transplant Laboratory that provides services to Sydney Children’s and Prince of Wales Hospitals, having worked in the cellular therapy field for more than 35 years. She was previously the Director of both the Sydney Cord Blood Bank and the BMDI Cord Blood Bank in Melbourne and has worked closely with Marcus Vowels and Reg Lam-Po-Tang who established the Sydney Cord Blood Bank and the Foundation.

Ms Leonie Wilcox

Manager, Registry

Ms Leonie Wilcox (RN,MN, BSc) has been the manager of the Australia and New Zealand Transplant and Cellular Therapies Registry (formerly ABMTRR) since 2006. Over this time, she has seen its growth and development as a clinical quality registry, acquisition of Commonwealth funding and inclusion of the national CAR-T registry. She has a passion for accurate data as the backbone for clinical quality monitoring and improvement and continues to support the TCT community in achieving its goals in providing high quality data driven care.